Preliminary results of beta-interferon treatment in the elderly

Controlled Clinical Trials

Volumn 17, Issue 2, 1996, Pages 123-129

  Terranova, R ^a   Luca, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

antiviral drug; chronic viral liver disease; patients over 60 years

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA INTERFERON;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE;

EID: 0029945498     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)80004-3     Document Type: Article

References (19)

1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M: Hepatitis C virus: The major causative agent of viral nonA, nonB hepatitis. Br Med Bull 46:423, 1990
2. Dienstag JL, Alter HJ: NonA, nonB hepatitis: Evolving epidemiologic and clinical perspective. Semir Liver Dis 6:67, 1986
3. Colombo M, Sangiovanni A, Donato MF, Tomassini M et al.: Anticorpi contro il virus dell'epatite C nei pazienti italiani con carcinoma epatocellulare. Arg Gastroent Clin 2:239, 1989
4. Colombo M: L'espatite virale C. Arg Gastroent Clin 3:133, 1990
5. Kiyosawa K, Sodeyama T, Nakano Y, Yoda H, et al.: Treatment of chronic nonA, nonB hepatitis with human interferon beta: A preliminary study. Antiviral Res 12: 151, 1989
6. Gibo Y, Kiyosawa K, Furuta K, Sodeyama T et al.: Long term outcome of nonA, nonB chronic hepatitis in comparison with that of type B chronic hepatitis. In YF Liaw ed., Chronic Hepatitis. Amsterdam, Elsevier, p. 221, 1986
7. Dianzani F: Il sistema degli interferon: proprietà biologiche ed applicazioni cliniche. Agg Med 14:489, 1990
8. Bocci V et al.: The lymphatic route. Distribution of human natural interferon beta in rabbit plasma and lymph. J Interferon Res 8:633, 1988
9. Terranova R, Luca S: Trattamento dell'epatite cronica C con interferone alfa ricombinante. Rass Med Interna 6:333, 1990
10. Terranova R, Luca S, Dimora AL: Epatite cronica C nell'anziano. Valutazione del trattamento con interferone alfa ricombinante. Giorn Gerontol 39:63, 1991
11. Terranova R, Luca S: Treatment of chronic hepatitis C with recombinant interferon alpha 2b. J Chemotherapy 5:297, 1992
12. Knodell RG, Ishak KG, Black WC et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431, 1981
13. Ajello A et al.: Trattamento dell'epatite cronica nonA, nonB con interferone alfa umano ricombinante. Interferons Cytokines 11:30, 1989
14. Lok ASF et al.: Incidence, neutralizing activity and clinical significance of interferon antibodies in chronic hepatitis B patients receiving recombinant alpha interferon. The 1990 International Symposium on Viral Hepatitis and Liver Disease. Houston, TX128, 4-8 April 1990
15. Arima T, Shimoimmura H, Nakagawa G: Treatment of nonA, nonB hepatitis with human fibroblast interferon. Hepatology 6:1117, 1986
16. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E: Comparative study of clinical, histological and immunological responses to interferon therapy in type nonA, nonB and type B chronic hepatitis. Am J Gastroent 85:24, 1990
17. Nishiguchi S, Kuroki T, Hirota S, Takeda T et al.: Interferon (IFN) therapy for chronic nonA, nonB hepatitis. Gastroenterology 95:A577, 1989
18. Ohnishi K, Nomura F, Iida S: Treatment of posttransfusion nonA, nonB acute and chronic hepatitis with human fibroblast beta interferon: a preliminary report. Am J Gastroent 84:596, 1989
19. Pocock SJ: Clinical Trial-A Practical Approach. New York, Wiley, 1983